Botulinum toxin A (Revance Therapeutics)

A型肉毒杆菌毒素(Revance Therapeutics)

Report date: 2026/05/25 20:02:40

Base Information

Drug NameBotulinum toxin A (Revance Therapeutics)
Drug Alias NameDaxibotulinumtoxinA Topical gelBoNTART-001(口服)RT-002(注射剂)daxibotulinumtoixnA +[14] 
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinklesGlabellar linesFacial wrinkles +[9] 
Global Approved IndicationsNasolabial fold wrinklesGlabellar lines
Approved Indications in ChinaNasolabial fold wrinkles
Original Approved Country/TerritoryUnited States
Original Approved Date2022/09/07
Country/TerritoryCzechiaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesRevance Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoMylan NvRevance Therapeutics Inc +[5] 
Inactive CompaniesN/A
Active IndicationsNasolabial fold wrinklesGlabellar linesSkin Abnormalities +[6] 
Inactive IndicationsFacial wrinklesTorticollisFasciitis, Plantar

Other Information

ATC CodeM03AX01
Related LinksWikipedia